TRPM8 promotes EMT in breast cancer cells (Liu et al. 2014), and N-(3-aminopropyl)-2-{[(3-methylphenyl) methyl]oxy}(20)-N-(2-thienylmethyl)benzamide, a TRPM8 inhibitor, suppresses proliferation and migration of breast cancer cell lines (Yapa et al. 2018). This evidence concerns the gene TRPM8 and breast carcinoma.